Search

Paul V. Ward

Examiner (ID: 4583)

Most Active Art Unit
1624
Art Unit(s)
1624, 1622, 1623
Total Applications
2519
Issued Applications
1801
Pending Applications
239
Abandoned Applications
539

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18181383 [patent_doc_number] => 20230042112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates [patent_app_type] => utility [patent_app_number] => 17/782500 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782500
A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates Dec 2, 2020 Pending
Array ( [id] => 18107882 [patent_doc_number] => 20230000762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => INJECTABLE HYDROGELS FOR CELL DELIVERY TO THE VITREOUS [patent_app_type] => utility [patent_app_number] => 17/781076 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781076 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781076
Injectable hydrogels for cell delivery to the vitreous Dec 2, 2020 Issued
Array ( [id] => 18272525 [patent_doc_number] => 20230093767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => COMPOSITION CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE, A PRESERVATIVE AND/OR ANTIOXIDANT, A SURFACTANT AND A POLYMER, AND THE METHOD FOR PROCESSING KERATIN MATERIALS FROM THE COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/781428 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781428 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781428
COMPOSITION CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE, A PRESERVATIVE AND/OR ANTIOXIDANT, A SURFACTANT AND A POLYMER, AND THE METHOD FOR PROCESSING KERATIN MATERIALS FROM THE COMPOSITION Dec 1, 2020 Pending
Array ( [id] => 18222089 [patent_doc_number] => 20230061083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => KRAS G12C INHIBITOR COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/779684 [patent_app_country] => US [patent_app_date] => 2020-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779684 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/779684
KRAS G12C INHIBITOR COMPOUND AND USE THEREOF Nov 26, 2020 Abandoned
Array ( [id] => 16976127 [patent_doc_number] => 20210220364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/104752 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30979 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104752 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104752
Combination therapy involving diaryl macrocyclic compounds Nov 24, 2020 Issued
Array ( [id] => 16711807 [patent_doc_number] => 20210078954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => GUANIDYL-CONTAINING P2Y12 RECEPTOR ANTAGONIST AND PREPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/105445 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7660 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 484 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105445 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/105445
Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof Nov 24, 2020 Issued
Array ( [id] => 18399298 [patent_doc_number] => 11661424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-30 [patent_title] => Process for preparing BTK inhibitors [patent_app_type] => utility [patent_app_number] => 17/102086 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102086
Process for preparing BTK inhibitors Nov 22, 2020 Issued
Array ( [id] => 18216392 [patent_doc_number] => 11591314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Process for preparing tetrahydrocarbazole carboxamide compound [patent_app_type] => utility [patent_app_number] => 17/101411 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17983 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101411 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101411
Process for preparing tetrahydrocarbazole carboxamide compound Nov 22, 2020 Issued
Array ( [id] => 18056583 [patent_doc_number] => 20220387669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT [patent_app_type] => utility [patent_app_number] => 17/775779 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775779 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/775779
CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT Nov 18, 2020 Pending
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 18887665 [patent_doc_number] => 11866426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Benzothiazole compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/098880 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31173 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3969 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098880
Benzothiazole compounds and uses thereof Nov 15, 2020 Issued
Array ( [id] => 18075776 [patent_doc_number] => 20220401388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION [patent_app_type] => utility [patent_app_number] => 17/776690 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776690 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/776690
METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION Nov 12, 2020 Pending
Array ( [id] => 18590191 [patent_doc_number] => 11739071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors [patent_app_type] => utility [patent_app_number] => 17/096349 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26071 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/096349
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Nov 11, 2020 Issued
Array ( [id] => 16868430 [patent_doc_number] => 20210161897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/094893 [patent_app_country] => US [patent_app_date] => 2020-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/094893
EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER Nov 10, 2020 Abandoned
Array ( [id] => 16688286 [patent_doc_number] => 20210070762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => SYNTHESIS OF COELENTERAZINE [patent_app_type] => utility [patent_app_number] => 17/089573 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16949 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/089573
Synthesis of coelenterazine Nov 3, 2020 Issued
Array ( [id] => 16839920 [patent_doc_number] => 20210147932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR [patent_app_type] => utility [patent_app_number] => 17/088119 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/088119
FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR Nov 2, 2020 Abandoned
Array ( [id] => 17385525 [patent_doc_number] => 20220033377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline [patent_app_type] => utility [patent_app_number] => 17/086666 [patent_app_country] => US [patent_app_date] => 2020-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/086666
Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline Nov 1, 2020 Abandoned
Menu